Rpl6 - ribosomal protein L6 Gene

Also Known as Taxreb107

Species: Mus musculus

Gene Type: protein coding
Gene ID: 19988

Summary

Predicted to enable 5.8S rRNA binding activity; mRNA binding activity; and tRNA binding activity. Predicted to be a structural constituent of ribosome. Predicted to be involved in cytoplasmic translation and ribosomal large subunit assembly. Located in postsynaptic density. Is expressed in several structures, including genitourinary system; intestine; liver; lung; and spleen. Orthologous to human RPL6 (ribosomal protein L6). [provided by Alliance of Genome Resources, Apr 2022]

Rpl6 Products (1)

mRNA Protein Name
NM_011290.5 NP_035420.2 60S ribosomal protein L6

Gene Ontology

  • Molecular Function
  • Cellular Component
Molecular Function GO Annotation Evidence References Source
enables structural constituent of ribosome IDA
IDA: Inferred from direct assay
36517592 MGI
Cellular Component GO Annotation Evidence References Source
located in cytoplasm IDA
IDA: Inferred from direct assay
36517592 MGI
part of cytosolic large ribosomal subunit IDA
IDA: Inferred from direct assay
36517592 MGI
part of cytosolic large ribosomal subunit IPI
IPI: Inferred from physical interaction
36517592 MGI
is active in postsynaptic density EXP
EXP: Inferred from Experiment
15169875 MGI
is active in postsynaptic density IDA
IDA: Inferred from direct assay
15169875 MGI
is active in synapse EXP
EXP: Inferred from Experiment
16635246 MGI
is active in synapse IDA
IDA: Inferred from direct assay
16635246 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

60S ribosomal protein L6

  • TAX-responsive enhancer element-binding protein 107

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
Cat. No. Product Name Effect
Purity Phase
HY-129239 Farudodstat 99.68% Phase 2

Pre-clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-121360 Cylindrospermopsin 98.76% Unkown
HY-RS12202 RPL6 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS18497 Rpl6 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS24979 Rpl6 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Rpl6 NCBI NCBI:6128